Clinical Trial Update: Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating denosumab’s impact on disseminated tumor cells in patients with early-stage breast cancer; study terminated with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Hope Rugo, MD | Conditions: Early Stage Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-01-02